Bone metastasis after stage IIIA non-small cell lung cancer: risks and prognosis.
作者信息
Bessa Camila Martins de, Silva Larissy Machado da, Zamboni Mauro Musa, Costa Guilherme Jorge, Bergmann Anke, Thuler Luiz Claudio Santos, Silva Gustavo Telles da
机构信息
. Universidade Federal do Rio de Janeiro, Rio de Janeiro (RJ), Brasil.
. Instituto Nacional de Câncer, Rio de Janeiro (RJ), Brasil.
出版信息
J Bras Pneumol. 2022 Nov 4;48(5):e20220211. doi: 10.36416/1806-3756/e20220211.
Abstract
摘要
相似文献
1
Bone metastasis after stage IIIA non-small cell lung cancer: risks and prognosis.
J Bras Pneumol. 2022 Nov 4;48(5):e20220211. doi: 10.36416/1806-3756/e20220211.
2
[Correlation between Lymph Node Ratio and Clinicopathological Features and Prognosis of IIIa-N2 Non-small Cell Lung Cancer].
Zhongguo Fei Ai Za Zhi. 2019 Nov 20;22(11):702-708. doi: 10.3779/j.issn.1009-3419.2019.11.04.
3
Prognostic stratification of patients with T3N1M0 non-small cell lung cancer: which phase should it be?
Med Oncol. 2012 Jun;29(2):607-13. doi: 10.1007/s12032-011-9907-y. Epub 2011 Mar 24.
4
Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study.
Int J Clin Oncol. 2019 Nov;24(11):1359-1366. doi: 10.1007/s10147-019-01483-1. Epub 2019 Jun 10.
5
[Survival Analysis of 121 Stage N2-IIIa Non-small Cell Lung Cancer Patients
Treated with Surgery].
Zhongguo Fei Ai Za Zhi. 2015 Aug;18(8):505-11. doi: 10.3779/j.issn.1009-3419.2015.08.06.
6
Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
Oncotarget. 2016 Feb 9;7(6):7227-40. doi: 10.18632/oncotarget.6979.
7
[Clinical and prognostic analysis of skip N2 metastases in stage IIIA-N2 non-small cell lung cancer].
Zhonghua Wai Ke Za Zhi. 2010 May 15;48(10):780-3.
8
[Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].
Ai Zheng. 2009 Jul;28(7):725-9. doi: 10.5732/cjc.008.10849.
9
Surgical outcome of stage IIIA- cN2/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004.
J Thorac Oncol. 2012 May;7(5):850-5. doi: 10.1097/JTO.0b013e31824c945b.
10
[Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Dtsch Med Wochenschr. 2006 Nov 24;131(47):2643-8. doi: 10.1055/s-2006-956268.
引用本文的文献
1
IL-17A deficiency inhibits lung cancer-induced osteoclastogenesis by promoting apoptosis of osteoclast precursor cells.
PLoS One. 2024 Feb 23;19(2):e0299028. doi: 10.1371/journal.pone.0299028. eCollection 2024.
本文引用的文献
1
Racial disparities in bone metastasis patterns and targeted screening and treatment strategies in newly diagnosed lung cancer patients.
Ethn Health. 2022 Feb;27(2):329-342. doi: 10.1080/13557858.2020.1734775. Epub 2020 Mar 28.
2
Non-small cell lung cancer in the very young: Higher EGFR/ALK mutation proportion than the elder.
J Chin Med Assoc. 2020 May;83(5):461-465. doi: 10.1097/JCMA.0000000000000311.
3
The homogeneous and heterogeneous risk factors for occurrence and prognosis in lung cancer patients with bone metastasis.
J Bone Oncol. 2019 Jul 9;17:100251. doi: 10.1016/j.jbo.2019.100251. eCollection 2019 Aug.
4
Prospective analysis of the association between skeletal-related events and quality of life in patients with advanced lung cancer (CSP-HOR13).
Oncol Lett. 2019 Jan;17(1):1320-1326. doi: 10.3892/ol.2018.9680. Epub 2018 Nov 9.
5
Bone metastases and skeletal-related events: incidence and prognosis according to histological subtype of lung cancer.
Future Oncol. 2019 Feb;15(5):485-494. doi: 10.2217/fon-2018-0613. Epub 2019 Jan 9.
6
Clinical Characteristics and Prognostic Factors in Bone Metastases from Lung Cancer.
Med Sci Monit. 2017 Aug 24;23:4087-4094. doi: 10.12659/msm.902971.
7
Health resource utilisation associated with skeletal-related events in patients with bone metastases secondary to solid tumours: regional comparisons in an observational study.
Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12452. Epub 2016 Feb 10.
8
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.
Sci Rep. 2015 Dec 22;5:18670. doi: 10.1038/srep18670.
9
Metastatic sites and survival in lung cancer.
Lung Cancer. 2014 Oct;86(1):78-84. doi: 10.1016/j.lungcan.2014.07.020. Epub 2014 Aug 2.
10
Controversies in the management of stage III non-small-cell lung cancer.
Expert Rev Anticancer Ther. 2014 Mar;14(3):333-47. doi: 10.1586/14737140.2014.867809. Epub 2014 Jan 8.
Zotero 插件